Business
BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
MINNEAPOLIS, Aug. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer
About this update from Bio-techne Corp
[{"type":"text","content":"MINNEAPOLIS, Aug. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences:\nMorgan Stanley 22nd Annual Global Healthcare ConferenceSeptember 4, 20244:05 PM EDT\n2024 Wells Fargo Healthcare ConferenceSeptember 6, 202411:00 AM EDT\nBaird 2024 Global Healthcare ConferenceSeptember 10, 20241:25 PM EDT\nA live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.\nAbout Bio-TechneBio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.\nContact:\nDavid Clair, Vice President, Investor Relations & Corporate [email protected] \n \n\n \n\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-investor-healthcare-conferences-302228184.html\nSOURCE Bio-Techne Corporation","length":5441,"tagName":"div"}]